metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Comparative efficacy & safety of buparlisib plus fulvestrant, fulvestrant plus d...
Journal Information

Statistics

Follow this link to access the full text of the article

Original articles
Comparative efficacy & safety of buparlisib plus fulvestrant, fulvestrant plus dalpiciclib, and ribociclib plus letrozole for postmenopausal, hormone receptor-positive, and HER2-negative breast cancer
Qi Liua, Lingli Houb,
Corresponding author
845430552@qq.com

Corresponding author.
, Ying Zhaob, Hongwei Yangb, Zhengying Moc, Fei Yud
a Department of Human Anatomy, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, PR China
b Department of Clinical Laboratory, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, PR China
c Department of Oncology, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, PR China
d Department of Clinical Laboratory, People's Hospital of Yunxi County, Yunxi, PR China
Read
676
Times
was read the article
225
Total PDF
451
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 16 7 23
2024 October 39 18 57
2024 September 53 17 70
2024 August 41 19 60
2024 July 38 23 61
2024 June 36 14 50
2024 May 46 30 76
2024 April 45 19 64
2024 March 29 12 41
2024 February 20 16 36
2024 January 62 20 82
2023 December 26 30 56

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos